Tag: psoriatic arthritis

All

The federal Food and Drug Administration has given its nod to Otezla (apremilast) for the treatment of adults with active psoriatic arthritis (PsA).

The nearly 2,500-patient study found no benefit from drain use, including among patients considered at higher risk for complications.